This activity will enable health care providers to recognize when risks of chronic opioid therapy outweigh benefits, and how to safely and compassionately taper patients down or off of chronic opioid therapy (including the use of buprenorphine to make this transition). A real life patient case scenario will be used to illustrate these principles in practice, including what to say to patients to communicate risks and provide support through the difficult period of withdrawal. When to refer for addiction treatment will also be discussed.
In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. ****
Credit Designation American Medical Association (AMA)
The Stanford University School of Medicine designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
If you would like to earn CME credit from Stanford University School of Medicine for participating in this course, please review the information here prior to beginning the activity.
Help others make their choice. Be the first one to leave a review